Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Bull Soc Pathol Exot ; 98(3): 224-9, 2005 Sep.
Artigo em Francês | MEDLINE | ID: mdl-16267965

RESUMO

Outbreaks of Ebola virus haemorrhagic fever have been reported from 1994 to 1996 in the province of Ogooué Ivindo, a forest zone situated in the Northeast of Gabon. Each time, the great primates had been identified as the initial source of human infection. End of November 2001 a new alert came from this province, rapidly confirmed as a EVHV outbreak. The response was given by the Ministry of Health with the help of an international team under the aegis of WHO. An active monitoring system was implemented in the three districts hit by the epidemic (Zadié, Ivindo and Mpassa) to organize the detection of cases and their follow-up. A case definition has been set up, the suspected cases were isolated at hospital, at home or in lazarets and serological tests were performed. These tests consisted of the detection of antigen or specific IgG and the RT-PCR. A classification of cases was made according to the results of biological tests, clinical and epidemiological data. The contact subjects were kept watch over for 21 days. 65 cases were recorded among which 53 deaths. The first human case, a hunter died on the 28th of October 2001. The epidemic spreads over through family transmission and nosocomial contamination. Four distinct primary foci have been identified together with an isolated case situated in the South East of Gabon, 580 km away from the epicenter. Deaths happened within a delay of 6 days. The last death has been recorded on the 22nd of March 2002 and the end of the outbreak was declared on the 6th of May 2002. The epidemic spreads over the Gabon just next. Unexplained deaths of animals had been mentionned in the nearby forests as soon as August 2001: great primates and cephalophus. Samples taken from their carcasses confirmed a concomitant animal epidemic.


Assuntos
Surtos de Doenças , Doença pelo Vírus Ebola/epidemiologia , Doenças dos Primatas/epidemiologia , Primatas/virologia , Animais , Antílopes/virologia , Anticorpos Antivirais/sangue , Anticorpos Antivirais/imunologia , Análise por Conglomerados , Busca de Comunicante , Infecção Hospitalar/epidemiologia , Infecção Hospitalar/transmissão , Reservatórios de Doenças , Ebolavirus/genética , Ebolavirus/imunologia , Ebolavirus/isolamento & purificação , Ebolavirus/patogenicidade , Seguimentos , Microbiologia de Alimentos , Gabão/epidemiologia , Gorilla gorilla/virologia , Haplorrinos/virologia , Doença pelo Vírus Ebola/diagnóstico , Doença pelo Vírus Ebola/mortalidade , Doença pelo Vírus Ebola/prevenção & controle , Doença pelo Vírus Ebola/transmissão , Doença pelo Vírus Ebola/veterinária , Humanos , Cooperação Internacional , Carne/virologia , Isolamento de Pacientes , Porcos-Espinhos/virologia , Doenças dos Primatas/transmissão , Doenças dos Primatas/virologia , Quarentena , RNA Viral/sangue , Estudos Retrospectivos , Testes Sorológicos , Organização Mundial da Saúde
2.
Bull Soc Pathol Exot ; 108(4): 235-41, 2015 Oct.
Artigo em Francês | MEDLINE | ID: mdl-26288132

RESUMO

According to the WHO records of 2013, the incidence of poliomyelitis was reduced by more than 99%, the number of endemic countries decreased from 125 in 1988 to 3 in 2013 and over 10 million cases were prevented from poliomyelitis thanks to the intensive use of Oral polio vaccine (OPV). However, the emergence of circulating vaccine-derived poliovirus strains (cVDPV), causing serious epidemics like the wild poliovirus, is a major challenge on the final straight towards the goal of eradication and OPV cessation. This paper describes the cVDPVoutbreak that occurred in the Democratic Republic of Congo (DRC) from November 2011 to April 2012. All children under 15 years of age with acute flaccid paralysis (AFP) and confirmed presence of cVDPV in the stool samples were included. Thirty (30) children, all from the administrative territories of Bukama and Malemba Nkulu in the Katanga Province (south-east DRC), were reported. The virus responsible was the cVDPV type 2 (0.7% -3.5% divergent from the reference Sabin 2 strain) in 29 children (97%) and the ambiguous vaccine-derived poliovirus strain (0.7% divergent) was confirmed in one case (3%), a boy seventeen months old and already vaccinated four times with OPV. Twentyfive children (83%) were protected by any of the routine EPI vaccines and 3 children (10%) had never received any dose of OPV. In reaction, DRC has conducted five local campaigns over a period of 10 months (from January to October 2012) and the epidemic was stopped after the second round performed in March 2012. As elsewhere in similar conditions, low immunization coverage, poor sanitation conditions and the stop of the use of OPV2 have favoured the emergence of the third cVDPV epidemic in DRC. The implementation of the Strategic Plan for Polio eradication and endgame strategic plan 2013-2018 will prevent the emergence of cVDPV and set up the conditions for a coordinated OPV phase out.


Assuntos
Surtos de Doenças , Poliomielite/epidemiologia , Poliomielite/prevenção & controle , Vacina Antipólio Oral/efeitos adversos , Poliovirus/imunologia , Vacinação/efeitos adversos , Adolescente , Criança , Pré-Escolar , República Democrática do Congo/epidemiologia , Erradicação de Doenças , Surtos de Doenças/estatística & dados numéricos , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Poliomielite/virologia , Estudos Soroepidemiológicos , Vacinação/estatística & dados numéricos
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa